Back to Results
First PageMeta Content
Abortifacients / Gynaecology / Antiandrogens / Mifepristone / Medical abortion / Pharmaceutical Benefits Scheme / Abortion in India / Women on Web / Abortion / Human reproduction / Fertility


The Pharmaceutical Benefits Advisory Committee (PBAC) [removed] 13 February 2013 Dear Chair and Committee Members Submission by the Public Health Association of Australia (PHAA) on RU486 (Mifepristone) W
Add to Reading List

Open Document

File Size: 251,66 KB

Share Result on Facebook

Country

Australia / Switzerland / Scotland / Sweden / /

/

Event

Diplomatic Relations / /

Facility

Australian Institute of Health / /

/

IndustryTerm

abortion services / covered services / Appropriate protocols / online training module / /

Organization

Pharmaceutical Benefits Advisory Committee / Public Health Association of Australia / Australian Institute of Health and Welfare / Medicare / Therapeutic Goods Administration / /

Person

Michael Moore / /

/

Position

Chair / Governor / Chief Executive Officer / /

ProvinceOrState

South Australia / /

Region

South Australia / /

URL

www.phaa.net.au / /

SocialTag